These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38570234)

  • 1. Asymmetric and symmetric dimethylarginine as markers of endothelial dysfunction in cerebrovascular disease: A prospective study.
    Bima C; Parasiliti-Caprino M; Rumbolo F; Ponzetto F; Gesmundo I; Nonnato A; Fornengo P; Vaula G; Ghigo E; Mengozzi G; Settanni F
    Nutr Metab Cardiovasc Dis; 2024 Jul; 34(7):1639-1648. PubMed ID: 38570234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The L-arginine pathway in acute ischemic stroke and severe carotid stenosis: temporal profiles and association with biomarkers and outcome.
    Molnar T; Pusch G; Papp V; Feher G; Szapary L; Biri B; Nagy L; Keki S; Illes Z
    J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2206-2214. PubMed ID: 25018114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia.
    Vögeli A; Ottiger M; Meier MA; Steuer C; Bernasconi L; Kulkarni P; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
    Respir Res; 2017 Jan; 18(1):25. PubMed ID: 28114935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High clinical accuracy of asymmetric dimethylarginine and symmetric dimethylarginine in patients with ischemic heart disease.
    Djordjević BV; Pavlović R; Ćosić V; Deljanin-Ilić M; Ristić T; Krstić N; Jevtović-Stoimenov T
    Amino Acids; 2012 Dec; 43(6):2293-300. PubMed ID: 22555650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival.
    Winkler MS; Nierhaus A; Rösler G; Lezius S; Harlandt O; Schwedhelm E; Böger RH; Kluge S
    Crit Care; 2018 Sep; 22(1):216. PubMed ID: 30231905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke.
    Schulze F; Carter AM; Schwedhelm E; Ajjan R; Maas R; von Holten RA; Atzler D; Grant PJ; Böger RH
    Atherosclerosis; 2010 Feb; 208(2):518-23. PubMed ID: 19700158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum L-arginine and dimethylarginine levels in migraine patients with brain white matter lesions.
    Erdélyi-Bótor S; Komáromy H; Kamson DO; Kovács N; Perlaki G; Orsi G; Molnár T; Illes Z; Nagy L; Kéki S; Deli G; Bosnyák E; Trauninger A; Pfund Z
    Cephalalgia; 2017 May; 37(6):571-580. PubMed ID: 27206959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Serum Levels of Asymmetric Dimethylarginine and Symmetric Dimethylarginine and Decreased Levels of Arginine in Sudanese Patients with Essential Hypertension.
    Gamil S; Erdmann J; Schwedhelm E; Bakheit KH; Abdalrahman IBB; Mohamed AO
    Kidney Blood Press Res; 2020; 45(5):727-736. PubMed ID: 32814314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Vögeli A; Ottiger M; Meier MA; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
    Lung; 2017 Dec; 195(6):717-727. PubMed ID: 28852826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low homoarginine/SDMA ratio is associated with poor short- and long-term outcome after stroke in two prospective studies.
    Choe CU; Lezius S; Cordts K; Gerloff C; Böger RH; Schwedhelm E; Grant PJ
    Neurol Sci; 2020 Jan; 41(1):149-153. PubMed ID: 31482247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
    Emrich IE; Zawada AM; Martens-Lobenhoffer J; Fliser D; Wagenpfeil S; Heine GH; Bode-Böger SM
    Clin Res Cardiol; 2018 Mar; 107(3):201-213. PubMed ID: 29101459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis.
    Chandrasekharan UM; Wang Z; Wu Y; Wilson Tang WH; Hazen SL; Wang S; Elaine Husni M
    Arthritis Res Ther; 2018 Jun; 20(1):123. PubMed ID: 29884228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High plasma dimethylarginine levels are associated with adverse clinical outcome after stroke.
    Worthmann H; Chen S; Martens-Lobenhoffer J; Li N; Deb M; Tryc AB; Goldbecker A; Dong Q; Kielstein JT; Bode-Böger SM; Weissenborn K
    J Atheroscler Thromb; 2011; 18(9):753-61. PubMed ID: 21566344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric dimethylarginine levels in thyroid diseases.
    Arikan E; Karadag CH; Guldiken S
    J Endocrinol Invest; 2007 Mar; 30(3):186-91. PubMed ID: 17505150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population.
    Wanby P; Teerlink T; Brudin L; Brattström L; Nilsson I; Palmqvist P; Carlsson M
    Atherosclerosis; 2006 Apr; 185(2):271-7. PubMed ID: 16055131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course of asymmetric dimethylarginine and symmetric dimethylarginine levels after successful renal transplantation.
    Claes KJ; Bammens B; Kuypers DR; Meijers B; Naesens M; Sprangers B; Vanrenterghem Y; Lerut E; de Loor H; Evenepoel P
    Nephrol Dial Transplant; 2014 Oct; 29(10):1965-72. PubMed ID: 24957811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symmetric dimethylarginine is a marker of detrimental outcome in the acute phase after ischaemic stroke: role of renal function.
    Lüneburg N; von Holten RA; Töpper RF; Schwedhelm E; Maas R; Böger RH
    Clin Sci (Lond); 2012 Feb; 122(3):105-11. PubMed ID: 21777201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study.
    Siegerink B; Maas R; Vossen CY; Schwedhelm E; Koenig W; Böger R; Rothenbacher D; Brenner H; Breitling LP
    Clin Res Cardiol; 2013 Mar; 102(3):193-202. PubMed ID: 23073705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), arginine, and 8-iso-prostaglandin F2alpha (8-iso-PGF2alpha) level in patients with inflammatory bowel diseases.
    Owczarek D; Cibor D; Mach T
    Inflamm Bowel Dis; 2010 Jan; 16(1):52-7. PubMed ID: 19575355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The relationship between serum asymmetric dimethylarginine and ABCD2 score in transient ischemic attack patients].
    Zhang Y; Fan D; Zhang N
    Zhonghua Nei Ke Za Zhi; 2014 Nov; 53(11):876-9. PubMed ID: 25586358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.